失代偿期肝硬化-话题@MedSci

#失代偿期肝硬化#

13篇内容 | 694人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2200240, encodeId=85c0220024090, content=<a href='/topic/show?id=02f99235e23' target=_blank style='color:#2F92EE;'>#质子泵抑制剂#</a> <a href='/topic/show?id=937f53428df' target=_blank style='color:#2F92EE;'>#慢加急性肝衰竭#</a> <a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=学术前沿｜Hepatol Commun：质子泵抑制剂治疗是失代偿期肝硬化患者发生慢加急性肝衰竭的危险因素, objectType=article, longId=821343, objectId=baef821343f2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=baef821343f2, replyNumber=0, likeNumber=3, createdTime=2024-04-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=baef821343f2, moduleTitle=学术前沿｜Hepatol Commun：质子泵抑制剂治疗是失代偿期肝硬化患者发生慢加急性肝衰竭的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=baef821343f2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1694691, encodeId=1b411694691cf, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=Clin Trans Gastroenterology：靶向白蛋白输注不能改善失代偿期肝硬化的全身炎症或心血管功能, objectType=article, longId=725577, objectId=1689e2557796, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1689e2557796, replyNumber=0, likeNumber=50, createdTime=2022-05-17, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1689e2557796, moduleTitle=Clin Trans Gastroenterology：靶向白蛋白输注不能改善失代偿期肝硬化的全身炎症或心血管功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1689e2557796)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694690, encodeId=bd9d169469068, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=J HEPATOLOGY：尿液中肝脏脂肪酸结合蛋白(L-FABP)是失代偿期肝硬化患者慢性肝衰竭和死亡率的预后生物标志物, objectType=article, longId=217902, objectId=5acc21e902a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5acc21e902a0, replyNumber=0, likeNumber=45, createdTime=2022-05-02, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5acc21e902a0, moduleTitle=J HEPATOLOGY：尿液中肝脏脂肪酸结合蛋白(L-FABP)是失代偿期肝硬化患者慢性肝衰竭和死亡率的预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5acc21e902a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694689, encodeId=47ca16946896e, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=Am J Gastroenterol：相对肾上腺皮质功不全是失代偿期肝硬化患儿发生并发症的危险因素！, objectType=article, longId=216978, objectId=ad722169e874, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad722169e874, replyNumber=0, likeNumber=36, createdTime=2022-03-09, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad722169e874, moduleTitle=Am J Gastroenterol：相对肾上腺皮质功不全是失代偿期肝硬化患儿发生并发症的危险因素！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad722169e874)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694686, encodeId=67c8169468625, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=Gastroenterology：白蛋白治疗对失代偿期肝硬化患者系统性和门静脉血流动力学及系统性炎症的影响, objectType=article, longId=174445, objectId=0ebb1e4445dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ebb1e4445dc, replyNumber=0, likeNumber=35, createdTime=2019-10-27, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ebb1e4445dc, moduleTitle=Gastroenterology：白蛋白治疗对失代偿期肝硬化患者系统性和门静脉血流动力学及系统性炎症的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ebb1e4445dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694688, encodeId=ea371694688e9, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=Lancet Gastroen Hepatol：辛伐他汀联合利福昔明用于失代偿期肝硬化患者安全性研究, objectType=article, longId=180995, objectId=993d1809954a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=993d1809954a, replyNumber=0, likeNumber=43, createdTime=2020-08-21, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=993d1809954a, moduleTitle=Lancet Gastroen Hepatol：辛伐他汀联合利福昔明用于失代偿期肝硬化患者安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=993d1809954a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694687, encodeId=bef2169468edf, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=J Gastroenterology：治疗顽固性腹水可以减轻肌肉质量的减少并提高失代偿期肝硬化患者的生存率, objectType=article, longId=179695, objectId=fd8d1e969584, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd8d1e969584, replyNumber=0, likeNumber=47, createdTime=2020-08-16, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd8d1e969584, moduleTitle=J Gastroenterology：治疗顽固性腹水可以减轻肌肉质量的减少并提高失代偿期肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd8d1e969584)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694684, encodeId=84dc169468427, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, objectType=article, longId=157446, objectId=175b15e44699, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=175b15e44699, replyNumber=0, likeNumber=46, createdTime=2019-06-16, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=175b15e44699, moduleTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=175b15e44699)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694685, encodeId=53aa1694685ed, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=Clinical and Translational Gastro：血清鞘脂可作为住院失代偿期肝硬化患者营养不良的生物标志物, objectType=article, longId=163741, objectId=a1df163e4184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1df163e4184, replyNumber=0, likeNumber=33, createdTime=2019-07-16, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1df163e4184, moduleTitle=Clinical and Translational Gastro：血清鞘脂可作为住院失代偿期肝硬化患者营养不良的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1df163e4184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694683, encodeId=a6d3169468391, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=Clin Transl Gastroenterol：失代偿期肝硬化合并糖尿病：自发性细菌性腹膜炎风险增加, objectType=article, longId=150346, objectId=676f15034652, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=676f15034652, replyNumber=0, likeNumber=48, createdTime=2019-08-28, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=676f15034652, moduleTitle=Clin Transl Gastroenterol：失代偿期肝硬化合并糖尿病：自发性细菌性腹膜炎风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=676f15034652)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694681, encodeId=6c7c1694681e9, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=【重复】Lancet：延长失代偿期肝硬化患者生命人血白蛋白真这么神奇？, objectType=article, longId=144327, objectId=b8de14432e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8de14432e9e, replyNumber=0, likeNumber=34, createdTime=2019-01-04, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8de14432e9e, moduleTitle=【重复】Lancet：延长失代偿期肝硬化患者生命人血白蛋白真这么神奇？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8de14432e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694682, encodeId=b2d51694682d4, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=欧洲失代偿期肝硬化并发症管理指南简介, objectType=article, longId=145069, objectId=275d14506961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=275d14506961, replyNumber=0, likeNumber=26, createdTime=2019-05-04, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=275d14506961, moduleTitle=欧洲失代偿期肝硬化并发症管理指南简介, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=275d14506961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694680, encodeId=33c9169468087, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=Hepatology：利福昔明或对失代偿期肝硬化的血流动力学无影响！, objectType=article, longId=96611, objectId=86a3966117c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86a3966117c, replyNumber=0, likeNumber=37, createdTime=2017-08-02, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86a3966117c, moduleTitle=Hepatology：利福昔明或对失代偿期肝硬化的血流动力学无影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86a3966117c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1694679, encodeId=f44216946e93f, content=<a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代偿期肝硬化#</a>, objectTitle=EASL 2014：骨髓内皮祖细胞治疗失代偿期肝硬化安全可行, objectType=article, longId=33360, objectId=e93c33360dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e93c33360dd, replyNumber=0, likeNumber=40, createdTime=2014-07-06, rootId=0, userName=kord1992, userId=f87729715654, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e93c33360dd, moduleTitle=EASL 2014：骨髓内皮祖细胞治疗失代偿期肝硬化安全可行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e93c33360dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

失代偿期肝硬化

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#质子泵抑制剂# #慢加急性肝衰竭# #失代偿期肝硬化#

学术前沿｜Hepatol Commun：质子泵抑制剂治疗是失代偿期肝硬化患者发生慢加急性肝衰竭的危险因素

2024-04-24发表于陕西省

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

Clin Trans Gastroenterology：靶向白蛋白输注不能改善失代偿期肝硬化的全身炎症或心血管功能

2022-05-17

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

J HEPATOLOGY：尿液中肝脏脂肪酸结合蛋白(L-FABP)是失代偿期肝硬化患者慢性肝衰竭和死亡率的预后生物标志物

2022-05-02

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

Am J Gastroenterol：相对肾上腺皮质功不全是失代偿期肝硬化患儿发生并发症的危险因素！

2022-03-09

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

Gastroenterology：白蛋白治疗对失代偿期肝硬化患者系统性和门静脉血流动力学及系统性炎症的影响

2019-10-27

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

Lancet Gastroen Hepatol：辛伐他汀联合利福昔明用于失代偿期肝硬化患者安全性研究

2020-08-21

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

J Gastroenterology：治疗顽固性腹水可以减轻肌肉质量的减少并提高失代偿期肝硬化患者的生存率

2020-08-16

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析

2019-06-16

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

Clinical and Translational Gastro：血清鞘脂可作为住院失代偿期肝硬化患者营养不良的生物标志物

2019-07-16

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

Clin Transl Gastroenterol：失代偿期肝硬化合并糖尿病：自发性细菌性腹膜炎风险增加

2019-08-28

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

【重复】Lancet：延长失代偿期肝硬化患者生命人血白蛋白真这么神奇？

2019-01-04

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

欧洲失代偿期肝硬化并发症管理指南简介

2019-05-04

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

Hepatology：利福昔明或对失代偿期肝硬化的血流动力学无影响！

2017-08-02

kord1992 (审核中...)

前往app查看评论内容

#失代偿期肝硬化#

EASL 2014：骨髓内皮祖细胞治疗失代偿期肝硬化安全可行

2014-07-06

科室
- - 订阅+
  - 更多科室
工具
服务